Pleiotropic roles of formyl peptide receptors

被引:168
作者
Le, YY [1 ]
Oppenheim, JJ [1 ]
Wang, JM [1 ]
机构
[1] Natl Canc Inst, Div Basic Sci, Mol Immunoregulat Lab, Frederick, MD 21702 USA
关键词
formyl peptide receptors; signal transduction; HIV-1; Alzheimer's disease;
D O I
10.1016/S1359-6101(01)00003-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FPR and FPRL1 belong to the seven-transmembrane, G protein-coupled chemoattractant receptor superfamily. Because of their capacity to interact with bacterial chemotactic formylated peptides. these receptors are thought to play a role in host defense against microbial infection. Recently, a variety of novel agonists have been identified for these receptors, including several host-derived endogenous molecules that are involved in proinflammatory responses. Most notably is the use of FPRL1 by at least three amyloidogenic protein and peptide ligands, the serum amyloid A (SAA), the 42 amino acid form of beta amyloid (A beta (42)), and the prion peptide PrP106-126, to chemoattract and activate human phagocytic leukocytes. These new findings have greatly expanded the functional scope of the formyl peptide receptors and call for more in-depth investigation of the role of these receptors in pathophysiological conditions. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 146 条
  • [101] Multiple activation steps of the N-formyl peptide receptor
    Prossnitz, ER
    Gilbert, TL
    Chiang, S
    Campbell, JJ
    Qin, SX
    Newman, W
    Sklar, LA
    Ye, RD
    [J]. BIOCHEMISTRY, 1999, 38 (08) : 2240 - 2247
  • [102] The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function
    Prossnitz, ER
    Ye, RD
    [J]. PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) : 73 - 102
  • [103] Prions
    Prusiner, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13363 - 13383
  • [104] G-PROTEIN-COUPLED CHEMOATTRACTANT RECEPTORS REGULATE LYN TYROSINE KINASE-CENTER-DOT-SHC ADAPTER PROTEIN SIGNALING COMPLEXES
    PTASZNIK, A
    TRAYNORKAPLAN, A
    BOKOCH, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) : 19969 - 19973
  • [105] QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167
  • [106] Identification of an N-foumyl peptide receptor ligand binding domain by a gain-of-function approach
    Quehenberger, O
    Pan, ZK
    Prossnitz, ER
    Cavanagh, SL
    Cochrane, CG
    Ye, RD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (02) : 377 - 381
  • [107] Rane MJ, 1997, J IMMUNOL, V159, P5070
  • [108] NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN ALZHEIMERS-DISEASE
    RICH, JB
    RASMUSSON, DX
    FOLSTEIN, MF
    CARSON, KA
    KAWAS, C
    BRANDT, J
    [J]. NEUROLOGY, 1995, 45 (01) : 51 - 55
  • [109] ROGERS J, 1995, ARZNEIMITTEL-FORSCH, V45-1, P439
  • [110] CLINICAL-TRIAL OF INDOMETHACIN IN ALZHEIMERS-DISEASE
    ROGERS, J
    KIRBY, LC
    HEMPELMAN, SR
    BERRY, DL
    MCGEER, PL
    KASZNIAK, AW
    ZALINSKI, J
    COFIELD, M
    MANSUKHANI, L
    WILLSON, P
    KOGAN, F
    [J]. NEUROLOGY, 1993, 43 (08) : 1609 - 1611